New research: A mini-version of antibodies, called nanobodies, could eventually be used to treat neurocognitive disorders.
The approach could expedite the antibody-creation process and accelerate the discovery of therapeutic antibody candidates and vaccines.
Stanford scientists produced a common cancer drug – previously only available from an endangered plant – in a common laboratory plant. This work could lead to a more stable supply of the drug and allow scientists to manipulate that drug to make it even safer and more effective.
A miniature device that combines optogenetics – using light to control the activity of the brain – with a newly developed technique for wirelessly powering implanted devices is the first fully internal method of delivering optogenetics. The blue glowing device the size of a peppercorn can activate neurons of the brain, spinal cord or limbs in mice and is powered wirelessly using the mouse's own body to transfer energy. Represents collaboration PI and Post Docs, multi-discipline, Known4 Labs.
A new microscope could provide unique insights into treating immune disorders and cancer. Stanford News reports on a collaboration of pediatric immunology and electrical engineering researchers which has developed a microscope that can rapidly measure the mechanical properties of cells at the nanometer scale.
A new microscope could provide unique insights into treating muscular degenerative diseases. Stanford News reports on a collaboration of scientists in bioengineering, biology and applied physics which has developed a microscope that can visualize and measure the force-generating contractions of these patients' individual motor units.
New optogenetic tools for watching brain nerves send signals in real time will make it easier to study brain functions and help develop therapies for brain diseases. Stanford News reports on two scientists who have worked together to create tools to observe the glowing trails of light spreading between connected nerves.